Loomis, Sayles & Company’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57
| Closed | -$11K | – | 803 |
|
|
2025
Q1 | $11K | Sell |
57
-3
| -5% | -$547 | ﹤0.01% | 712 |
|
|
2024
Q4 | $11K | Hold |
60
| – | – | ﹤0.01% | 706 |
|
|
2024
Q3 | $14K | Buy |
+60
| New | +$12.9K | ﹤0.01% | 683 |
|
|
2024
Q1 | – | Sell |
-65
| Closed | -$10K | – | 964 |
|
|
2023
Q4 | $10K | Buy |
+65
| New | +$8.75K | ﹤0.01% | 793 |
|
|
2023
Q3 | – | Sell |
-41
| Closed | -$6K | – | 1025 |
|
|
2023
Q2 | $6K | Buy |
+41
| New | +$5.72K | ﹤0.01% | 814 |
|
|
2022
Q4 | – | Sell |
-13
| Closed | -$1K | – | 986 |
|
|
2022
Q3 | $1K | Sell |
13
-77
| -86% | -$7.96K | ﹤0.01% | 931 |
|
|
2022
Q2 | $9K | Sell |
90
-9
| -9% | -$1.13K | ﹤0.01% | 680 |
|
|
2022
Q1 | $14K | Buy |
+99
| New | +$13.7K | ﹤0.01% | 668 |
|
|
2021
Q4 | – | Sell |
-68
| Closed | -$9K | – | 906 |
|
|
2021
Q3 | $9K | Sell |
68
-75
| -52% | -$11.4K | ﹤0.01% | 854 |
|
|
2021
Q2 | $21K | Buy |
143
+68
| +91% | +$10.3K | ﹤0.01% | 674 |
|
|
2021
Q1 | $10K | Buy |
+75
| New | +$9.95K | ﹤0.01% | 794 |
|
|
2019
Q2 | – | Sell |
-32,358
| Closed | -$4.33M | – | 739 |
|
|
2019
Q1 | $4.33M | Sell |
32,358
-128
| -0.4% | -$16.9K | 0.01% | 454 |
|
|
2018
Q4 | $3.79M | Sell |
32,486
-2,236
| -6% | -$281K | 0.01% | 440 |
|
|
2018
Q3 | $4.44M | Sell |
34,722
-5,021
| -13% | -$616K | 0.01% | 486 |
|
|
2018
Q2 | $4.43M | Sell |
39,743
-1,053
| -3% | -$123K | 0.01% | 527 |
|
|
2018
Q1 | $4.83M | Sell |
40,796
-11,073
| -21% | -$1.32M | 0.01% | 539 |
|
|
2017
Q4 | $5.88M | Sell |
51,869
-3,293
| -6% | -$352K | 0.01% | 509 |
|
|
2017
Q3 | $6.12M | Sell |
55,162
-6,979
| -11% | -$786K | 0.01% | 499 |
|
|
2017
Q2 | $7.59M | Sell |
62,141
-5,348
| -8% | -$637K | 0.02% | 462 |
|
|
2017
Q1 | $8.4M | Sell |
67,489
-3,598
| -5% | -$425K | 0.02% | 441 |
|
|
2016
Q4 | $7.56M | Sell |
71,087
-16,223
| -19% | -$1.92M | 0.02% | 477 |
|
|
2016
Q3 | $10.8M | Sell |
87,310
-24,234
| -22% | -$3.07M | 0.03% | 411 |
|
|
2016
Q2 | $15M | Sell |
111,544
-1,224
| -1% | -$161K | 0.04% | 349 |
|
|
2016
Q1 | $14.1M | Sell |
112,768
-1,940
| -2% | -$218K | 0.04% | 365 |
|
|
2015
Q4 | $13.7M | Sell |
114,708
-26,105
| -19% | -$3.19M | 0.04% | 371 |
|
|
2015
Q3 | $17.6M | Sell |
140,813
-2,749
| -2% | -$383K | 0.05% | 317 |
|
|
2015
Q2 | $20.4M | Sell |
143,562
-51,199
| -26% | -$6.41M | 0.06% | 317 |
|
|
2015
Q1 | $22.9M | Sell |
194,761
-4,249
| -2% | -$470K | 0.06% | 290 |
|
|
2014
Q4 | $22.1M | Sell |
199,010
-452
| -0.2% | -$47.5K | 0.06% | 299 |
|
|
2014
Q3 | $20.8M | Sell |
199,462
-96,000
| -32% | -$10.2M | 0.06% | 298 |
|
|
2014
Q2 | $28.3M | Sell |
295,462
-61,148
| -17% | -$5.28M | 0.08% | 236 |
|
|
2014
Q1 | $29.3M | Sell |
356,610
-11,670
| -3% | -$939K | 0.08% | 228 |
|
|
2013
Q4 | $29.9M | Sell |
368,280
-61,513
| -14% | -$4.91M | 0.09% | 221 |
|
|
2013
Q3 | $32.2M | Sell |
429,793
-5,051
| -1% | -$352K | 0.1% | 209 |
|
|
2013
Q2 | $29.1K | Buy |
+434,844
| New | +$28.7M | 0.1% | 216 |
|
Other funds holding UHS
Loomis, Sayles & Company's UHS Position: Q2 2025 in Review
Loomis, Sayles & Company sold out of Universal Health Services (UHS) in Q2 2025, closing a stake of 57 shares — an estimated $11K sold.
Loomis, Sayles & Company first reported a position in UHS in Q2 2013 and held it in 35 quarters. The position peaked at $32.2M in Q3 2013. 622 funds tracked by Wall St. Rank hold UHS as of Q2 2025.
- Loomis, Sayles & Company reported no remaining Universal Health Services position as of Q2 2025 after selling out during the quarter.
- Loomis, Sayles & Company sold 57 Universal Health Services shares in Q2 2025, an estimated $11K.
- Loomis, Sayles & Company first reported a position in Universal Health Services in Q2 2013 and held it in 35 quarters.
- Loomis, Sayles & Company's Universal Health Services position peaked at $32.2M in Q3 2013.
- 622 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2025.
Based on Loomis, Sayles & Company's 13F filing for Q2 2025, filed 13 Aug 2025.